Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Change in Cash (2016 - 2026)

Protara Therapeutics' Change in Cash history spans 14 years, with the latest figure at -$34.9 million for Q1 2026.

  • Quarterly Change in Cash rose 51.05% to -$34.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$76.7 million through Mar 2026, down 295.57% year-over-year, with the annual reading at -$113.1 million for FY2025, 191.83% down from the prior year.
  • Change in Cash came in at -$34.9 million for Q1 2026, down from $37.1 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $111.0 million in Q4 2024 to a low of -$71.3 million in Q1 2025.
  • The 5-year median for Change in Cash is -$210000.0 (2023), against an average of -$1.2 million.
  • The largest YoY upside for Change in Cash was 1808.58% in 2024 against a maximum downside of 17911.43% in 2024.
  • Protara Therapeutics' Change in Cash stood at -$23.4 million in 2022, then surged by 124.89% to $5.8 million in 2023, then skyrocketed by 1808.58% to $111.0 million in 2024, then crashed by 66.58% to $37.1 million in 2025, then plummeted by 194.11% to -$34.9 million in 2026.
  • Per Business Quant, the three most recent readings for TARA's Change in Cash are -$34.9 million (Q1 2026), $37.1 million (Q4 2025), and -$18.9 million (Q3 2025).